Literature DB >> 11566777

Divergent effects of the malignant hyperthermia-susceptible Arg(615)-->Cys mutation on the Ca(2+) and Mg(2+) dependence of the RyR1.

E M Balog1, B R Fruen, N H Shomer, C F Louis.   

Abstract

The sarcoplasmic reticulum (SR) Ca(2+) release channel (RyR1) from malignant hyperthermia-susceptible (MHS) porcine skeletal muscle has a decreased sensitivity to inhibition by Mg(2+). This diminished Mg(2+) inhibition has been attributed to a lower Mg(2+) affinity of the inhibition (I) site. To determine whether alterations in the Ca(2+) and Mg(2+) affinity of the activation (A) site contribute to the altered Mg(2+) inhibition, we estimated the Ca(2+) and Mg(2+) affinities of the A- and I-sites of normal and MHS RyR1. Compared with normal SR, MHS SR required less Ca(2+) to half-maximally activate [(3)H]ryanodine binding (K(A,Ca): MHS = 0.17 +/- 0.01 microM; normal = 0.29 +/- 0.02 microM) and more Ca(2+) to half-maximally inhibit ryanodine binding (K(I,Ca): MHS = 519.3 +/- 48.7 microM; normal = 293.3 +/- 24.2 microM). The apparent Mg(2+) affinity constants of the MHS RyR1 A- and I-sites were approximately twice those of the A- and I-sites of the normal RyR1 (K(A,Mg): MHS = 44.36 +/- 4.54 microM; normal = 21.59 +/- 1.66 microM; K(I,Mg): MHS = 660.8 +/- 53.0 microM; normal = 299.2 +/- 24.5 microM). Thus, the reduced Mg(2+) inhibition of the MHS RyR1 compared with the normal RyR1 is due to both an enhanced selectivity of the MHS RyR1 A-site for Ca(2+) over Mg(2+) and a reduced Mg(2+) affinity of the I-site.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566777      PMCID: PMC1301678          DOI: 10.1016/S0006-3495(01)75854-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  28 in total

Review 1.  Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors.

Authors:  G Meissner
Journal:  Annu Rev Physiol       Date:  1994       Impact factor: 19.318

2.  Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia.

Authors:  J R Mickelson; E M Gallant; L A Litterer; K M Johnson; W E Rempel; C F Louis
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

3.  Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.

Authors:  B Dietze; J Henke; H M Eichinger; F Lehmann-Horn; W Melzer
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

4.  Bound and determined: a computer program for making buffers of defined ion concentrations.

Authors:  S P Brooks; K B Storey
Journal:  Anal Biochem       Date:  1992-02-14       Impact factor: 3.365

5.  Differential Ca(2+) sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin.

Authors:  B R Fruen; J M Bardy; T M Byrem; G M Strasburg; C F Louis
Journal:  Am J Physiol Cell Physiol       Date:  2000-09       Impact factor: 4.249

6.  Altered binding site for Ca2+ in the ryanodine receptor of human malignant hyperthermia.

Authors:  H H Valdivia; K Hogan; R Coronado
Journal:  Am J Physiol       Date:  1991-08

7.  Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.

Authors:  J Fujii; K Otsu; F Zorzato; S de Leon; V K Khanna; J E Weiler; P J O'Brien; D H MacLennan
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

8.  Stimulation and inhibition of [3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs.

Authors:  J R Mickelson; L A Litterer; B A Jacobson; C F Louis
Journal:  Arch Biochem Biophys       Date:  1990-04       Impact factor: 4.013

9.  Cellular membrane potentials and contractile threshold in mammalian skeletal muscle susceptible to malignant hyperthermia.

Authors:  E M Gallant; G A Gronert; S R Taylor
Journal:  Neurosci Lett       Date:  1982-02-12       Impact factor: 3.046

10.  Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor.

Authors:  N H Shomer; C F Louis; M Fill; L A Litterer; J R Mickelson
Journal:  Am J Physiol       Date:  1993-01
View more
  13 in total

1.  Aging impairs regulation of ryanodine receptors from extensor digitorum longus but not soleus muscles.

Authors:  Angela J Gaboardi; Jochen Kressler; Teresa K Snow; Edward M Balog
Journal:  Muscle Nerve       Date:  2018-01-30       Impact factor: 3.217

Review 2.  Regulation of the RyR channel gating by Ca2+ and Mg2.

Authors:  Derek R Laver
Journal:  Biophys Rev       Date:  2018-06-20

3.  Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.

Authors:  Wei Feng; Genaro C Barrientos; Gennady Cherednichenko; Tianzhong Yang; Isela T Padilla; Kim Truong; Paul D Allen; José R Lopez; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2010-12-14       Impact factor: 4.436

4.  Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.

Authors:  Takashi Murayama; Toshiharu Oba; Hiroshi Hara; Kikuo Wakebe; Noriaki Ikemoto; Yasuo Ogawa
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

5.  Interdomain interactions within ryanodine receptors regulate Ca2+ spark frequency in skeletal muscle.

Authors:  Alexander Shtifman; Christopher W Ward; Takeshi Yamamoto; Jianli Wang; Beth Olbinski; Hector H Valdivia; Noriaki Ikemoto; Martin F Schneider
Journal:  J Gen Physiol       Date:  2002-01       Impact factor: 4.086

Review 6.  Structural Insight Into Ryanodine Receptor Channelopathies.

Authors:  Hadiatullah Hadiatullah; Zhao He; Zhiguang Yuchi
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

Review 7.  Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure.

Authors:  Alexander Dashwood; Elizabeth Cheesman; Nicole Beard; Haris Haqqani; Yee Weng Wong; Peter Molenaar
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-01

8.  Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia.

Authors:  Dawei Jiang; Wenqian Chen; Jianmin Xiao; Ruiwu Wang; Huihui Kong; Peter P Jones; Lin Zhang; Bradley Fruen; S R Wayne Chen
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

9.  Luminal Ca2+-regulated Mg2+ inhibition of skeletal RyRs reconstituted as isolated channels or coupled clusters.

Authors:  Derek R Laver; Erin R O'Neill; Graham D Lamb
Journal:  J Gen Physiol       Date:  2004-11-15       Impact factor: 4.086

10.  Genetics of Malignant Hyperthermia: A Brief Update.

Authors:  David Beebe; Vikram V Puram; Srdjan Gajic; Bharat Thyagarajan; Kumar G Belani
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.